The transcription factor nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) is crucial for immune responses and skeletal development. Work in recent years has shown that various members of the NF-κB family are viable targets to regulate activity and survival of bone cells and hence bone metabolism. In this regard, deletion of upstream kinases or distal NF-κB subunits resulted with bone deformities. Thus, it has become increasingly apparent that detailed investigation of NF-κB in bone cells may provide opportunities to design new therapeutic modalities. In this chapter we present modified methodology describing efficient approaches to regulate the NF-κB pathway in vitro and in vivo to assess its function in bone cells and tissues.
CITATION STYLE
Swarnkar, G., & Abu-Amer, Y. (2015). Regulation of NF-κB signaling in osteoclasts and myeloid progenitors. Methods in Molecular Biology, 1280, 527–542. https://doi.org/10.1007/978-1-4939-2422-6_31
Mendeley helps you to discover research relevant for your work.